Viveve Medical, Inc.
VIVE · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,684 | $1,795 | $1,641 | $1,706 |
| % Growth | -6.2% | 9.4% | -3.8% | – |
| Cost of Goods Sold | $1,138 | $1,501 | $1,321 | $1,747 |
| Gross Profit | $546 | $294 | $320 | -$41 |
| % Margin | 32.4% | 16.4% | 19.5% | -2.4% |
| R&D Expenses | $1,800 | $1,921 | $2,140 | $2,861 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,408 | $3,393 | $3,653 | $3,085 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$22 | -$40 | -$21 | -$7 |
| Operating Expenses | $5,208 | $5,314 | $5,793 | $5,946 |
| Operating Income | -$4,662 | -$5,020 | -$5,473 | -$5,987 |
| % Margin | -276.8% | -279.7% | -333.5% | -350.9% |
| Other Income/Exp. Net | -$314 | -$324 | -$291 | -$273 |
| Pre-Tax Income | -$4,976 | -$5,344 | -$5,764 | -$6,260 |
| Tax Expense | $0 | $779 | $413 | $68 |
| Net Income | -$5,290 | -$6,123 | -$6,177 | -$6,328 |
| % Margin | -314.1% | -341.1% | -376.4% | -370.9% |
| EPS | -0.5 | -0.58 | -0.58 | -0.63 |
| % Growth | 13.8% | 0% | 7.9% | – |
| EPS Diluted | -0.5 | -0.58 | -0.58 | -0.63 |
| Weighted Avg Shares Out | 10,665 | 10,641 | 10,620 | 10,090 |
| Weighted Avg Shares Out Dil | 10,665 | 10,641 | 10,620 | 10,090 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $292 | $284 | $270 | $266 |
| Depreciation & Amortization | $174 | $188 | $204 | $240 |
| EBITDA | -$4,510 | -$4,872 | -$5,290 | -$5,754 |
| % Margin | -267.8% | -271.4% | -322.4% | -337.3% |